摘要
干细胞治疗是一种很有前途的视网膜变性(RD)的治疗方法。我们以爱尔兰皇家外科学院(RCS)大鼠研究人类脂肪干细胞(hADSCs)的影响。 方法:绿色荧光蛋白(GFP)标记的细胞在人类脂肪干细胞视网膜移植到出生后(PN)21天的爱尔兰皇家外科学院大鼠去探索潜在的治疗作用,而腺相关病毒载体(AAV2)血管内皮生长因子(VEGF)和siRNA人类脂肪干细胞用来进行机械清扫。通过视网膜电图(ERG)记录视觉功能。转分化的潜力进行免疫荧光(IF)和基因表达的定量反转录聚合酶链反应(qRT-PCR)分析。视网膜细胞凋亡的检测采用原位缺口末端标记(TUNEL),采用酶联免疫吸附(ELISA)测定人类脂肪干细胞因子分泌。 结果:爱尔兰皇家外科学院大鼠视功能在打开眼睛后一周后开始下降,它们是在出生后3周打开他们的眼睛,出生后 5周几乎失去,伴随着视网膜外核层(ONL)损失。人类脂肪干细胞大鼠视网膜移植后2周明显改善视功能,这样的移植疗效持续8周治疗后(出生后 11周),3-4排感光细胞保持在视网膜外核层和减少细胞凋亡。与此同时,杆感光细胞标记基因的表达视网膜色素(Rho),CRX和视蛋白(opn1)在爱尔兰皇家外科学院出生后 3周表现出明显的下降趋势,但人类脂肪干细胞治疗的大鼠升高。细胞移植抑制Bax,Bak和caspase 3的表达,但不抗凋亡基因Bcl-2和Bcl-xL,包括。最后,大量的血管内皮生长因子,肝细胞生长因子(HGF)和色素上皮衍生因子(PEDF)分泌细胞进行检测,而内源性血管内皮生长因子的表达水平在爱尔兰皇家外科学院大鼠的时间减少。对腺相关病毒载体-血管内皮生长因子治疗具有疗效人类脂肪干细胞但人类脂肪干细胞基本上消失了血管内皮生长因子siRNA敲除的疗效。 结论:在爱尔兰皇家外科学院大鼠上进行人类脂肪干细胞移植视网膜细胞有效地延缓视网膜变性,增强视网膜细胞生存和改善视觉功能。这主要是由于细胞依赖的抗细胞凋亡和神经保护作用通过其生长及神经营养因子包括血管内皮生长因子的分泌人类脂肪干细胞优点的临床应用值得进一步研究。
关键词: 脂肪干细胞,视网膜变性,神经保护,细胞凋亡。
Current Molecular Medicine
Title:Human Adipose-Derived Stem Cells Delay Retinal Degeneration in Royal College of Surgeons Rats Through Anti-Apoptotic and VEGF-Mediated Neuroprotective Effects
Volume: 16 Issue: 6
Author(s): Z. Li, J. Wang, F. Gao, J. Zhang, H. Tian, X. Shi, C. Lian, Y. Sun, W. Li, J.-Y. Xu, P. Li, J. Zhang, Z. Gao, J. Xu, F and Wang, L. Lu, G.-T. Xu
Affiliation:
关键词: 脂肪干细胞,视网膜变性,神经保护,细胞凋亡。
摘要: Stem cell therapy is a promising therapeutic approach for retinal degeneration (RD). Our study investigated the effects of human adipose derived stem cell (hADSCs) on Royal College of Surgeons (RCS) rats.
Methods: Green fluorescent protein (GFP)-labeled hADSCs were transplanted subretinally into RCS rats at postnatal (PN) 21 days to explore potential therapeutic effects, while adeno-associated viral vector (AAV2)-vascular endothelial growth factor (VEGF) and siVEGF-hADSCs were used to aid the mechanistic dissections. Visual function was evaluated by Electroretinogram (ERG) recording. Potential transdifferentiations were examined by Immunofluorescence (IF) and gene expressions were analyzed by quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Apoptotic retinal cells were detected by Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) assay and the cytokines secreted by hADSCs were measured by Enzyme-linked Immunosorbent Assay (ELISA).
Results: The visual function of RCS rats began to decrease one week after their eyes opened at PN week 3 and almost lost in PN 5 weeks, accompanied by the loss of retinal outer nuclear layer (ONL). Subretinal transplantation of hADSCs significantly improved the visual function 2 weeks after the transplantation and such therapeutic effect persisted up to 8 weeks after the treatment (PN 11 weeks), with 3-4 rows of photoreceptors remained in the ONL and reduced apoptosis. Consistent with these phenotypic changes, the gene expression of rod photoreceptor markers Rhodopsin (Rho), Crx and Opsin (Opn1) in RCS rats showed obvious decreasing trends over time after PN 3 weeks, but were elevated with hADSC treatment. hADSC transplantation also repressed the expressions of Bax, Bak and Caspase 3, but not the expression of anti-apoptotic genes, including Bcl-2 and Bcl-XL. Finally, substantial VEGF, hepatocyte growth factor (HGF) and pigment epithelium-derived factor (PEDF) secretions from hADSCs were detected, while endogenous Vegf expression level decreased over time in RCS rats. The treatment of AAV2-VEGF showed comparable therapeutic effects as hADSCs but siRNA knockdown of VEGF in hADSCs essentially abolished the therapeutic effects.
Conclusions: Subretinal transplantation of hADSCs in RCS rats effectively delayed the retinal degeneration, enhanced the retinal cell survival and improved the visual function. Mechanistically this was mainly due to hADSC dependent anti-apoptotic and neuroprotective effects through its secretion of growth and neurotrophic factors including VEGF. Clinical application of hADSCs merits further investigation.
Export Options
About this article
Cite this article as:
Z. Li, J. Wang, F. Gao, J. Zhang, H. Tian, X. Shi, C. Lian, Y. Sun, W. Li, J.-Y. Xu, P. Li, J. Zhang, Z. Gao, J. Xu, F and Wang, L. Lu, G.-T. Xu , Human Adipose-Derived Stem Cells Delay Retinal Degeneration in Royal College of Surgeons Rats Through Anti-Apoptotic and VEGF-Mediated Neuroprotective Effects, Current Molecular Medicine 2016; 16 (6) . https://dx.doi.org/10.2174/1566524016666160607090538
DOI https://dx.doi.org/10.2174/1566524016666160607090538 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabolic Syndrome and Myocardial Infarction in Women
Current Pharmaceutical Design Cannabinoid System as a Potential Target for Drug Development in the Treatment of Cardiovascular Disease
Current Vascular Pharmacology Low Dose of Anisodine Hydrobromide Induced Neuroprotective Effects in Chronic Cerebral Hypoperfusion Rats
CNS & Neurological Disorders - Drug Targets Redox Homeostasis, Bioactive Agents and Transduction Therapy
Current Signal Transduction Therapy Flavonols and Flavones – Protecting Against Myocardial Ischemia/ Reperfusion Injury by Targeting Protein Kinases
Current Medicinal Chemistry Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide
Current Pharmaceutical Biotechnology Mechanisms of Action and Chemical-Biological Interactions Between Ozone and Body Compartments: A Critical Appraisal of the Different Administration Routes
Current Drug Therapy High Throughput Metabolomics in Clinical Studies: Review and New Applications to Remote Ischemic Preconditioning
Current Topics in Medicinal Chemistry Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches
Current Pharmaceutical Design Role of Tyrosine Isomers in Acute and Chronic Diseases Leading to Oxidative Stress - A Review
Current Medicinal Chemistry Epigenetic Evaluation of N-(2-hydroxyphenyl)-2-Propylpentanamide, a Valproic Acid Aryl Derivative with Activity Against HeLa Cells
Current Molecular Pharmacology Low-Molecular Weight Heparins in Percutaneous Coronary Interventions: Current Concepts, Problems, and Perspectives
Current Pharmaceutical Design Admission, 24 Hours and Discharge Troponin T Among Acute Myocardial Infarction Patients: Differing by Prognostic Contribution
Recent Patents on Biomarkers Pharmacological Inhibition of Interleukin-8 (CXCL8) as a New Approach for the Prevention and Treatment of Several Human Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Pharmacologic Treatment of Pulmonary Arterial Hypertension
Current Pharmaceutical Design Heat Shock Paradox and a New Role of Heat Shock Proteins and their Receptors as Anti-Inflammation Targets
Inflammation & Allergy - Drug Targets (Discontinued) Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets
Current Pharmaceutical Design Low Lymphocyte Count and Cardiovascular Diseases
Current Medicinal Chemistry Pain Management in Hematological Patients with Major Organ Dysfunctions and Comorbid Illnesses
Cardiovascular & Hematological Agents in Medicinal Chemistry Bioactive Compounds in Diabetic Cardiomyopathy: Current Approaches and Potential Diagnostic and Therapeutic Targets
Cardiovascular & Hematological Agents in Medicinal Chemistry